REPROCELL

REPROCELL's corporate vision is to promote human health by providing cutting-edge research products, services, and partnerships that advance the future of Regenerative Medicine.

Our RNA-based GMP iPSC Master Cell Bank manufacturing is compliant with regulatory standards of FDA, EMA, and PMDA. Our ready-to use clinical iPSC Seed Stocks can be evaluated for suitability or we can prepare a custom Seed Clone bank to meet the Sponsor's specifications.

For drug development programs, REPROCELL provides custom assay services using functional human tissues or 3D tissue models to demonstrate the efficacy and safety of investigational drugs. The operational capabilities to support global clinical trial needs range from routine peripheral blood mononuclear cell (PBMC) processing to more complex genomic, proteomic, and cellular analyses.